Penelope M. Drake
- Obstetrics and Gynecology top 2%
- Pregnancy and preeclampsia studies 5
-
- Monoclonal and Polyclonal Antibodies Research 16
- Immunology top 5%
- Reproductive System and Pregnancy 4
- Oncology top 5%
- HER2/EGFR in Cancer Research 12
- Peptidase Inhibition and Analysis 4
- CAR-T cell therapy research 3
- Reproductive Medicine top 5%
-
- Chemical Synthesis and Analysis 5
-
- Click Chemistry and Applications 3
- Co-authors
- David RabukaSusan J. FisherRobyn M. BarfieldKristy Red-HorseMichael D. GunnLesley JonesRomas KudirkaStefanie Bañas
- Journals
- Molecular Cancer Therapeutics (3 papers)Bioconjugate Chemistry (3 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Penelope M. Drake
33 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 92
- Obstetrics and Gynecology 297
- Radiology, Nuclear Medicine and Imaging 597
- Immunology 511
- Oncology 649
- Reproductive Medicine 129
Countries citing papers authored by Penelope M. Drake
This map shows the geographic impact of Penelope M. Drake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Penelope M. Drake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Penelope M. Drake more than expected).
Fields of papers citing papers by Penelope M. Drake
This network shows the impact of papers produced by Penelope M. Drake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Penelope M. Drake. The network helps show where Penelope M. Drake may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Penelope M. Drake, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2020 | 11 | |
| 3 | 2019 | 46 | |
| 4 | 2017 | 22 | |
| 5 | 2017 | 82 | |
| 6 | 2016 | 9 | |
| 7 | 2016 | 38 | |
| 8 | 2015 | 53 | |
| 9 | 2015 | 52 | |
| 10 | 2014 | 24 | |
| 11 | 2014 | 40 | |
| 12 | 2014 | 31 | |
| 13 | 2014 | 168 | |
| 14 | 2013 | 127 | |
| 15 | 2013 | 97 | |
| 16 | 2013 | 3 | |
| 17 | 2004 | 53 | |
| 18 | 2004 | 64 | |
| 19 | 2002 | 17 | |
| 20 | 2001 | 132 |
About Penelope M. Drake
Penelope M. Drake is a scholar working on Obstetrics and Gynecology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 33 papers that have together received 1.9k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (16 papers), HER2/EGFR in Cancer Research (12 papers), Pregnancy and preeclampsia studies (5 papers), Chemical Synthesis and Analysis (5 papers), Peptidase Inhibition and Analysis (4 papers), Reproductive System and Pregnancy (4 papers), Click Chemistry and Applications (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Obstetrics and Gynecology (297 citations), Radiology, Nuclear Medicine and Imaging (597 citations) and Immunology (511 citations). Penelope M. Drake has collaborated with scholars based in United States, Germany and France. Frequent co-authors include David Rabuka, Susan J. Fisher, Robyn M. Barfield, Kristy Red-Horse, Michael D. Gunn, Lesley Jones, Romas Kudirka, Stefanie Bañas, Aaron E. Albers and Birgit Schilling. Their work appears in journals such as Molecular Cancer Therapeutics, Bioconjugate Chemistry, Journal of Clinical Investigation, mAbs and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.